BORTEZOMIB PLUS DEXAMETHASONE IN COMBINATION WITH MELPHALAN OR CYCLOPHOSPHAMIDE IN THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA

被引：0
|
作者：
Tsirigotis, P. [1 ]
Girkas, K. G. [1 ]
Giannopoulou, V. [1 ]
Chondropoulos, S. [1 ]
Ioannidou, E. [1 ]
Papaxoinis, G. [1 ]
Pappa, V. [1 ]
Vasilatou, D. [1 ]
Dimoula, K. [1 ]
Kapodistrias, N. [1 ]
Papageorgiou, E. [1 ]
Economopoulos, T. [1 ]
Dervenoulas, J. [1 ]
机构：
[1] ATTIKON Gen Univ Hosp, Athens, Greece
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1109
引用
收藏
页码：436 / 436
页数：1
相关论文
共 50 条
  • [21] BORTEZOMIB, LOW DOSE INTRAVENOUS MELPHALAN AND DEXAMETHASONE FOR PATIENTS WITH RELAPSED MULTIPLE MYELOMA
    Popat, R.
    Oakervee, H.
    Williams, C.
    Cook, M.
    Craddock, C.
    Basu, S.
    Singer, C.
    Odeh, L.
    Foot, N.
    Joel, S.
    Hallam, S.
    Harding, S.
    Mead, G.
    Cavenagh, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 365 - 366
  • [22] Bortezomib, low dose iv melphalan and dexamethasone for patients with relapsed multiple myeloma
    Popat, R.
    Williams, C.
    Cook, M.
    Craddock, C.
    Basu, S.
    Singer, C.
    Odeh, L.
    Foot, N.
    Joel, S.
    Hallam, S.
    Oakervee, H.
    Cavenagh, J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 120 - 120
  • [23] Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma
    Bahlis, Nizar J.
    Sutherland, Heather
    White, Darrell
    Sebag, Michael
    Lentzsch, Suzanne
    Kotb, Rami
    Venner, Christopher P.
    Gasparetto, Cristina
    Del Col, Aldo
    Neri, Paola
    Reece, Donna
    Kauffman, Michael
    Shacham, Sharon
    Unger, T. J.
    Jeha, Jacqueline
    Saint-Martin, Jean-Richard
    Shah, Jatin
    Chen, Christine
    BLOOD, 2018, 132 (24) : 2546 - 2554
  • [24] Bendamustine and prednisone in combination with Bortezomib in the treatment of patients with relapsed/refractory multiple myeloma
    Poenisch, W.
    Bourgeois, M.
    Heyn, S.
    Wagner, I
    Jaekel, N.
    Rohrberg, R.
    Hurtz, H. -J.
    Schmalfeld, M.
    Assmann, M.
    Edelmann, T.
    Mohren, M.
    Hoffmann, F. A.
    Schwarzer, A.
    Hensel, G.
    Loeschke, K.
    Becker, C.
    Krahl, R.
    Al-Ali, H. K.
    Niederwieser, D.
    ONKOLOGIE, 2012, 35 : 144 - 144
  • [25] A Phase II Trial of Chloroquine in Combination with Bortezomib and Cyclophosphamide in Patients with Relapsed and Refractory Multiple Myeloma
    Montanari, Francesca
    Lu, Meina
    Marcus, Sara
    Saran, Ankeeta
    Malankar, Aditya
    Mazumder, Amitabha
    BLOOD, 2014, 124 (21)
  • [26] Bortezomib in combination with bendamustine and preduisone in the treatment of patients with refractory/relapsed multiple myeloma
    Poenisch, Wolfram
    Bourgeois, Malvina
    Wang, Song-Yau
    Heyn, Simone F.
    Jaekel, Nadja
    Braunert, Leanthe
    Rohrberg, Robert
    Hurtz, Hans Juergen
    Hoffmann, Franz Albert
    Schwarzer, Andreas
    Becker, Cornelia
    Al Ali, Haifa
    Niederwieser, Dietger W.
    BLOOD, 2007, 110 (11) : 799A - 800A
  • [27] Bortezomib in combination with bendamustine and prednisone in the treatment of patients with refractory/relapsed multiple myeloma
    Poenisch, W.
    Bourgeois, M.
    Wang, S. Y.
    Heyn, S.
    Jaekel, N.
    Al Ali, H.
    Niederwieser, D.
    ONKOLOGIE, 2008, 31 : 136 - 136
  • [28] Bortezomib in combination with melphalan in the treatment of relapsed or refractory multiple myeloma: A phase I/II study.
    Berenson, J
    Yang, H
    Swift, R
    Sadler, K
    Vescio, R
    Adams, J
    Schenkein, D
    BLOOD, 2004, 104 (11) : 64A - 64A
  • [29] BORTEZOMIB IN COMBINATION WITH DEXAMETHASONE FOR THE TREATMENT OF ELDERLY PATIENTS AFFECTED BY REFRACTORY MULTIPLE MYELOMA
    Villa, M. R.
    Lucania, A.
    Esposito, M.
    Della Cioppa, P.
    Improta, S.
    Russolillo, S.
    Mastrullo, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 621 - 621
  • [30] Safety and efficacy of daratumumab in combination with bortezomib and dexamethasone in Japanese patients with relapsed or refractory multiple myeloma
    Shinsuke Iida
    Tatsuo Ichinohe
    Atsushi Shinagawa
    Kenshi Suzuki
    Naoki Takezako
    Masayuki Aoki
    International Journal of Hematology, 2018, 107 : 460 - 467
12345